Rutin plus vitamin C attenuate acute doxorubicin-induced liver toxicity in rats
Naunyn-Schmiedeberg's Archives of Pharmacology · 17.11.2026
DOI: 10.1007/s00210-026-06067-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 17.11.2026. Verfasst von Ikenna Chukwuemeka Maduako und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chemoprevention & Toxicology Laboratory, Department of Medical Biochemistry, College of Medical Sciences, Benson Idahosa University, Benin City, Nige…. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Doxorubicin (DOX) is widely used to treat hepatocellular carcinoma, but its use is limited by dose-dependent hepatotoxicity associated with oxidative stress and inflammation. Protective adjunct therapies that reduce liver injury without compromising anticancer efficacy remain a clinical challenge. Here, we evaluated the hepatoprotective effects of combined rutin and vitamin C administration in a rat model of acute DOX-induced liver injury. Forty-eight male albino rats (170–180 g) were randomly assigned to six groups of eight animals each: group I (distilled water vehicle control, orally), group II (DOX alone, 15 mg/kg intraperitoneally on day 12), group III (metformin, 250 mg/kg orally, daily + DOX), group IV (VitC+DOX), group V (RUT+DOX), and group VI (RUT+VitC+DOX). All groups except the control received a single intraperitoneal injection of DOX (15 mg/kg) on day 12, after daily oral dosing from days 1 to 14. Animals were sacrificed on day 14 to capture the acute phase of DOX-induced hepatotoxicity, which is well documented to peak within 48–72 h after high single doses of anthracyclines. Biochemical assays, oxidative stress markers, pro-inflammatory mediators, and histopathological analyses showed that co-treatment significantly restored antioxidant enzyme activities, reduced lipid peroxidation and reactive oxygen/nitrogen species, and attenuated inflammatory responses compared with DOX alone. The combination was statistically superior to either agent alone across all primary endpoints, with biochemical improvements comparable in magnitude to those observed in the metformin reference group. Histological analysis confirmed that combination therapy preserved liver architecture. These results indicate that co-administration of rutin and vitamin C provides greater hepatoprotection than either agent alone and may serve as an adjunctive strategy to mitigate DOX-induced hepatotoxicity. Graphical Abstract In a mouse experiment, daily oral dosing lasted 14 days, with doxorubicin, or DOX, given at 15 milligrams per kilogram on day 12 and euthanasia on day 14. Groups were control, Met plus DOX, vitamin C plus DOX, RUT plus DOX, and RUT plus vitamin C plus DOX. Outcomes were oxidative stress, liver damage, and inflammation. DOX toxicity is associated with increased ROS and MDA, ALT and AST, and TNF-alpha and IL-1 beta; treatments are shown reducing oxidative stress, liver injury, and inflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chemoprevention & Toxicology Laboratory, Department of Medical Biochemistry, College of Medical Sciences, Benson Idahosa University, Benin City, Nigeria. imaduako@biu.edu.ng.
- Department of Biochemistry, Faculty of Life Science, University of Benin, Benin City, Nigeria.
- Department of Public Health, Imo State University, Owerri, Nigeria.
Zitieren
APA
Maduako, I. C., Maduako, C. V., & Igwe, C. N. (2026). Rutin plus vitamin C attenuate acute doxorubicin-induced liver toxicity in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06067-1
Vancouver
Maduako IC, Maduako CV, Igwe CN. Rutin plus vitamin C attenuate acute doxorubicin-induced liver toxicity in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06067-1
BibTeX
@article{Maduako2026,
author = {Maduako, Ikenna Chukwuemeka and Maduako, Chinweokwu Valerie and Igwe, Chidinma Nkem},
title = {Rutin plus vitamin C attenuate acute doxorubicin-induced liver toxicity in rats},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-06067-1}
}
EUVIMED